Background: The lateral transpsoas approach to interbody fusion is a less disruptive but direct-visualization approach for anterior/ anterolateral fusion of the thoracolumbar spine. Several reports have detailed the technique, the safety of the approach, and the short term clinical benefits. However, no published studies to date have reported the long term clinical and radiographic success of the procedure.
Lumbar interbody fusion has been recognized as an advantageous procedure in the management of degenerative conditions. 1, 2 Although interbody fusion has been successful with high patient satisfaction and fusion rates, [3] [4] [5] [6] [7] traditional open approaches to the spine have reportedly led to complications such as excessive blood loss, iatrogenic muscle and soft tissue injury, muscular denervation and loss of strength, and increased postoperative pain. 8, 9 Minimally disruptive approaches to spinal fusion have been gaining popularity as surgeons seek to reduce approach-related morbidity, improve cosmesis, and enhance a speedy recovery and return to normal activity. 8 -17 In recent history, challenges have hindered wide-spread implementation of many minimally invasive techniques. Most techniques have been accomplished through the use of tubular exposures and endoscopic visualization. Working coaxially through tubular portals limits anatomical access and relies on 2-dimensional images for visualization, thus requiring thorough knowledge of the 3-dimensional (3-D) spinal anatomy with recognition of anatomical landmarks within limited fields of view. Additionally, tubular exposures can be technically challenging as they require working in a smaller window with longer instruments, 9 which can be associated with a steep learning curve. Consequently, these limitations have been thought by some to result in having to compromise underlying surgical objectives for minimally invasive benefits.
Surgical approaches, however, need not use tubular exposures and endoscopic visualization to gain less invasive benefits. Traditional exposures have been reduced in size in recent years to "mini-open" access, retaining conventional surgical techniques such as direct visualization and the use of standard instruments and implants, and resulting in both lower postoperative morbidity and ultimate clinical success. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] The lateral transpsoas or extreme lateral interbody fusion approach is one such example. It is a variation on the mini-open anterior lumbar interbody fusion (ALIF) procedure-approaching the anterolateral spine through the retroperitoneal fat and psoas major muscle-and it provides the surgeon with a less invasive access to the anterior lumbar spine and direct visualization for disk space distraction and fusion. While this approach and its early outcomes have been well described, 18, 27, 28, [31] [32] [33] [34] [35] there is little reported on the long-term results of lateral interbody fusion in the literature.
Materials and methods
The current study is a retrospective chart review of prospectively collected clinical and radiographic outcomes in patients having undergone the anterolateral transpsoas approach procedure at a single academic institution for anterior column stabilization as treatment for degenerative conditions.
Patient selection and surgical indications
Patients were considered candidates for this surgery if they presented with axial low back pain or radiculopathy due to degenerative conditions, and if they failed at least 6 months of conservative, traditional nonoperative management. Indications are not dissimilar to those for traditional ALIF. Contraindications included severe central canal stenosis, rotatory scoliosis that precluded a lateral approach, and moderate to severe spondylolisthesis (ՆGrade 3). In some patients, discography was used as a tool to assist in level selection.
During preoperative consultation, all patients were informed of all surgical options. A complete discussion and description of the approach technique, as has been reported in detail in the literature, 18 ,27,28 was described to all patients interested in the procedure. Informed consent for surgery was attained for every patient.
Clinical outcomes
Institutional review board (IRB) approval was obtained to retrospectively review the charts of patients who underwent the anterolateral transpsoas procedure at a single academic institution between 2003 and December 2006. All patients who were a minimum 2 years post-surgery were included in the analysis.
Chart review included compilation of demographics (age, gender), symptoms and diagnosis, surgical details (levels treated, instrumentation used, blood loss, complications), hospital stay, additional procedures, results of physical exams, late-occurring complications and patient complaints, prospectively collected back and leg pain scores (visual analog scale, VAS) and functional outcome scores (Oswestry disability index, ODI, as well as radiographic fusion assessment). Radiographic review included assessment of fusion at 12 months, 24 months, or beyond. Fusion was defined as bridging trabecular bone and lack of lucencies on plain radiographs. Additionally, patients without symptomatic pseudarthrosis, regardless of appearance on radiographs, were classified as clinically fused.
Statistical methods
Differences in clinical outcomes scores from preoperative to 2 years postoperative time-points were tested using paired t tests. Influences of demographic and other descriptive characteristics on the outcomes were evaluated using t tests for continuous variables and 2 tests for categorical variables as appropriate. All hypothesis testing was performed with a level of significance of .05.
Results
Sixty-two consecutive patients met inclusion criteria for this study. Patients averaged 63.8 years of age (range, 31-88), and were 55% female. Primary diagnoses included 35.5% degenerative scoliosis, 32.2% DDD, 22.6% spondylolisthesis, and 9.7% stenosis. Presenting symptoms included 21% with isolated low back pain, 7% with isolated radicular pain, and 72% combined back and leg pain.
In total, 113 levels were treated. Twenty-six procedures (42%) were single-level, 13 (21%) 2-level, and 23 (37%) 3-or more levels. Forty-eight surgeries (77%) included the L4-5 level. Forty-five (73%) included supplemental posterior pedicle fixation, 4 (6%) lateral fixation, and 13 (21%) were standalone. Fifty-seven (92%) included the use of bone morphogenic protein (BMP), the remainder a mixture of allograft and autograft.
Mean operative time, estimated blood loss, and hospital stay were 240 minutes per patient (156 minutes per level), 183 cc per patient (91 cc per level), and 5 days (range, 1-18), respectively. Early in our experience, multi-level procedures (long-construct scoliosis cases typically) were staged, with an average 5 days between anterior reconstruction and posterior instrumentation. Excluding the staged procedures, hospital stays averaged 3.9 days. The majority of patients needed only Vicodin and NSAIDs for analgesia and ambulated on postoperative day 1.
There were no major and 12 (19%) minor complications. These included 3 wound-related events (psoas hematoma identified on postoperative imaging, but not requiring treatment; retroperitoneal dilated colon, not requiring intervention; and a superficial wound infection), 3 respiratory (1 asthma exacerbation; 2 pneumothorax: 1 in a T11-L4 case, and 1 in an L1-4 case following a staged posterior procedure for T12-L5 instrumentation, both identified on postoperative x-ray imaging, but inconsequential, not requiring intervention), 2 gastrointestinal (ileus), 2 cardiovascular (postoperative atrial fibrillation, anemia secondary to blood loss), 1 renal (urinary tract infection), and 1 pseudarthrosis.
Immediate postoperative hip flexion weakness was common, as was bilateral transient upper thigh numbness, as a consequence of the transpsoas approach. These were generally resolved within the first 6 weeks post-surgery. No new postoperative motor neural deficits were detected via standard-of-care physical exams, nor via patient complaint.
Clinical outcomes are charted over time in Fig. 1 . Pain scores (VAS) decreased significantly from preoperative to 2 years follow-up by 37% (P Ͻ .0001). Functional scores (ODI) decreased by 39% from preoperative to 2 years follow-up (P Ͻ .0001). Clinical success, as defined by minimum 15-point decrease in ODI, was achieved in 71% of patients.
Diagnosis was statistically confounding in patient age (P ϭ .0133), the number of levels treated (P Ͻ .0001), and length of hospital stay (P ϭ .0258), all of which were higher in the subset of patients with scoliosis. There was a small but statistical difference in the change in VAS scores due to diagnosis as well, with a slightly lower average improvement over the 2 years in scoliosis patients (P ϭ .0404). The numbers in each group were too small to determine an effect of diagnosis on the ODI outcomes.
Radiographically, fusion success was achieved in 91% of patients. One patient had a pseudarthrosis requiring revision (a 98.4% nonrevision success rate). A representative example of radiographic outcomes, including demonstrative disk height and alignment correction as well as fusion, is shown in Fig. 2 . There were no statistical differences in rates of fusion based on diagnosis (P Ͼ .05).
Discussion

The lateral transpsoas approach
The lateral transpsoas approach is a modification of the anterior retroperitoneal approach to the lumbar spine. The technique was first presented in 2001 by Pimenta, 31 and has since been reported by several authors as resulting in excellent short-term outcomes. 18, 27, 28, [31] [32] [33] [34] [35] When compared with traditional open and minimally invasive anterior approaches to the lumbar spine, the lateral approach has several advantages. The lateral approach avoids many of the recognized complications of direct anterior approaches, such as vascular injury 36, 37 and retrograde ejaculation.
38,39
The minimal complication rate reported herein supports prior reports on anterolateral fusion [32] [33] [34] [35] and the safety of the anterolateral approach. The results of the current study are also consistent with reported advantages of other minimally disruptive spinal procedures, including lower blood loss, less muscle atrophy, and superior postoperative trunk muscle strength which lead to a faster and less painful recovery period. 8 -17 Compared with other minimally disruptive techniques, the approach is a relatively straightforward procedure, with a comparatively short learning curve. It uses direct illuminated visualization, rather than endoscopes, allowing for full 3-D visual access as well as the use of standard instruments to complete the procedure effectively.
While it is an optimal choice for many patients, the anterolateral approach is not without restrictions. Patients with the occasional anatomical variance and those with extensive prior surgical scarring may not qualify. Anatomically, the iliac crest limits the potential exposure sites to levels above L5-S1. In addition, psoas traverse, though technically straightforward, must be done carefully so as not to injure the nerves of the lumbar plexus or cause significant trauma to the psoas muscle. Historically, lateral retroperitoneal approaches included mobilization and posterior retraction of the psoas muscle, but unacceptable rates of transient numbness along the genitofemoral nerve were documented. 40, 41 Use of discrete evoked threshold EMG monitoring is critical to the safe passage by the nerves within the psoas muscle. In addition, the preferentially anterior expan- Both pain and function were statistically significantly reduced at 2-years compared to preoperatively (P Ͻ .0001). The slight increase in VAS noted from 6 to 24 months was not statistically significant (P ϭ .6914), and is presumed to be contributed to by adjacent segment issues and other longitudinal problems unrelated to the primary procedure.
sion of the retractor limits subsequent psoas trauma and lumbar plexus injury.
Despite the purported advantages of less invasive techniques, there has been little documentation of long-term success rates to date.
Clinical outcomes
The operative times and hospital stays reported herein were greater than has been typically reported for this approach. These patients were the surgeons' first of these procedures, and so perhaps represented a learning curve with the technique. With respect to OR time, repositioning the patients for posterior instrumentation does add to the length of the procedure. With respect to length of hospitalization, the average 3.9 days was at the time of the surgeons' early experience with this approach considered a significant decrease from what had been common for interbody fusion at our institution. As the surgeons have become more experienced with this technique and the institution becomes more comfortable with the early recovery of these patients, length of stay continues to decrease.
The pain and function scores in the current study (37% decrease in pain scores and 39% change in ODI scores) are comparable to prior results of interbody fusion. Some of the highest level-of-evidence studies in recent literature are those reported from Food and Drug Administration (FDA) investigational device exemption (IDE) studies. Kuslich et al reported a 42% reduction in pain and 31% improvement in functional outcome. 42 Sasso et al saw an average 42% improvement in ODI scores. 43 The fusion controls from recent total disk replacement studies have further reported clinical success based on a minimum 15 point decrease in ODI score for each patient. ODI success was thus reported at rates between 50-55%. 44, 45 The same studies reported a 32-24% reduction in pain scores at 2 years. By the measure of the 15 point ODI change criterion, clinical success in the current study was achieved in 71% of patients. We attribute the higher ODI success rate in the current study to the inclusion of patients with radicular symptoms from degenerative stenosis, scoliosis, and spondylolisthesis, as opposed to prior studies on DDD and primarily low-back pain, resulting in a relatively higher preoperative baseline score as well as greater opportunity to provide relief through this procedure.
Fusion success
Radiographically, disk heights were restored and stability maintained by preserving ligamentous structures and inserting a large interbody implant, indirectly increasing foraminal volume and reducing radiculopathy. Sagittal balance was maintained or improved by placement of the implant in an anterior position. Coronal imbalances were corrected by ensuring full bilateral endplate coverage by the implant. Corrections were wellmaintained through successful arthrodesis. The fusion rates reported in this series are within the ranges of those reported from other fusion studies with an overall fusion rate of 91%. The FDA studies reported fusion rates between 90% and 99% using cages [42] [43] [44] [45] [46] [47] [48] [49] and between 52-75% using allograft spacers. The relationship between clinical and radiographic success has been debated. Patients who are asymptomatic but do not appear fully fused radiographically present a challenge in reporting success rates. Of the 12% of patients in this study who did not have bridging trabecular bone on plain radiographs, none had motion on flexion/extension films. One patient required posterior revision for pseudarthrosis. By a definition based on the requirement for revision surgery, the current study revision rate of 1.6% results in a nonrevision success rate of 98.4%. In contrast, the fusion cohort in the FDA study reported by Blumenthal et al resulted in a 9% revision rate for pseudarthrosis. 44 It was 5.4% in Zigler et al's report of circumferential fusion controls. 45 The lower revision rate in the current study is attributable, in the authors' opinion, to the differences between the procedures from a lateral and a direct anterior approach. Advantages include the ability to preserve the anterior longitudinal ligament and to place a large cage that sits on the ring apophysis bilaterally, both factors contributing to a more stable construct. Additionally, advances in grafting materials may also have contributed to this difference, as the current study used primarily BMP in the interspace, while the study by Blumenthal et al used threaded cylindrical cages (BAK) and autograft.
Limitations of the current study include its retrospective design. While surgical details and clinical outcomes questionnaires were prospectively collected, chart review is only as strong as the follow-up achieved. Longer-term outcomes were only available for a smaller segment of the original cohort. The authors believe the lack of full follow-up artificially skews the positive results of the procedure, since patients who are feeling well tend to decline continued evaluation, whereas those who are less than satisfied are more likely to return for continued care. Prospective multi-center studies with planned follow-up are underway and forthcoming publications may support or refute this assumption.
Fusion rates in the current study were evaluated by standing and flexion-extension radiographs, although it is increasingly common to assess fusion by thin-cut CT evaluation. Few of the patients in this series underwent CT evaluation for fusion; those who did demonstrated fusion, but the numbers were too small to be worthy of inclusion in this analysis. It has since become the authors' standard practice to obtain CTs for the evaluation of fusion between 6 and 12 months, and future reports will include this method of assessment.
Another confounding factor is the heterogeneous patient population. This study is one in a mix of patient demographics, pathologies, and treatment groups. Long-construct scoliosis cases may not be expected to have the same average results as short-construct spondylolisthesis, DDD, and other conditions. However, the average results here demonstrate that good outcomes may be generalized over a wide variety of patients.
Conclusion
The surgical results of this procedure have shown that anteriolateral fusion a safe and effective technique. It has demonstrated the benefits of a minimally disruptive procedure, with quick recovery and improvements in pain and function scales. As the first published report of 2-year outcomes following anterolateral fusion has also demonstrated that the underlying objectives of surgery need not be compromised for the sake of less morbidity, given long term maintenance of clinical improvements and ultimate radiographic fusion.
